Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
PubMed laboratory research record [PMID: 37007007] PubMed record related to this compound for laboratory literature review
Survodutide is another dual agonist in the pipeline with encouraging phase 2 data
Here for You: Do you test your products and provide COAs
TRACK YOUR GLP-1 ROUTINE: - Log your shot timely with smart reminders - Follow prescribed titration and dosing schedules - History of shots - dose, timing, injection sites - See estimated medication activity between doses - Monitor your weight loss progress at every dosage - Use the daily check-in to track cravings, mood, energy, bowel movements, and sleep quality - Analyze the response of each dose by tracking food noise and hunger levels - Smart injection site rotation - Side effects tracking and notes SCIENCE-BACKED SUPPORT - Weekly progress reports to review with your healthcare provider - Explore how your weight loss aligns with reported outcomes in clinical studies - Lifestyle recommendations grounded in official guidelines from the American Society for Nutrition (ASN), American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association - Wisdom feature searches clinical trials and peer-reviewed research to answer your GLP-1 questions, backed by real science REFILL AND SUPPLY TRACKING - Keep your full inventory: vials, pens, concentration, volume, and expiration dates (BUD)
Whether that translates into additive weight loss in humans is the open empirical question
The Danish pharma giant also recently got approval from the Chinese National Medical Products Administration to launch Wegovy in China
